Document is current
Any future updates will be listed below
-
Authors
Dassanayake, Rohana P.
Atkinson, Briony M.
Mullis, Adam S.
Falkenberg, Shollie M.
Nicholson, Eric M.
Casas, Eduardo
Narasimhan, Balaji
Bearson, Shawn M. D.
-
Funding
Funding for this research was provided by:
USDA/Agricultural Research Service, National Animal Disease Center (5030-32000-116-00D and 5030-32000-113-00D)
USDA/Agricultural Research Service, National Animal Disease Center (5030-32000-116-00D and 5030-32000-113-00D)
USDA/Agricultural Research Service, National Animal Disease Center (5030-32000-116-00D and 5030-32000-113-00D)
USDA/Agricultural Research Service, National Animal Disease Center (5030-32000-116-00D and 5030-32000-113-00D)
USDA/Agricultural Research Service, National Animal Disease Center (5030-32000-116-00D and 5030-32000-113-00D)
2020 USDA-ARS Antimicrobial Resistance and USDA-ARS Alternatives to Antibiotics Funding (0426572 and 0426570)
2020 USDA-ARS Antimicrobial Resistance and USDA-ARS Alternatives to Antibiotics Funding (0426572 and 0426570)
2020 USDA-ARS Antimicrobial Resistance and USDA-ARS Alternatives to Antibiotics Funding (0426572 and 0426570)
2020 USDA-ARS Antimicrobial Resistance and USDA-ARS Alternatives to Antibiotics Funding (0426572 and 0426570)
2020 USDA-ARS Antimicrobial Resistance and USDA-ARS Alternatives to Antibiotics Funding (0426572 and 0426570)
- License Information
-
More Information
Article History
Received: 25 May 2021
Accepted: 14 September 2021
First Online: 29 September 2021
Competing interests
: B.N. is a co-founder of ImmunoNanoMed Inc., a start-up with business interests in the development of nano-based vaccines against infectious diseases. The other authors declare no competing interests.
